Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses.

about

Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses.

Item

http://www.wikidata.org/entity/Q42325413

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Clopidogrel compared with othe ...... d cost-effectiveness analyses.

@en

Clopidogrel compared with othe ...... d cost-effectiveness analyses.

@nl

type

Item

label

Clopidogrel compared with othe ...... d cost-effectiveness analyses.

@en

Clopidogrel compared with othe ...... d cost-effectiveness analyses.

@nl

prefLabel

Clopidogrel compared with othe ...... d cost-effectiveness analyses.

@en

Clopidogrel compared with othe ...... d cost-effectiveness analyses.

@nl

P1476

Clopidogrel compared with othe ...... d cost-effectiveness analyses.

@en

P2093

A Brown

http://www.w3.org/2001/XMLSchema#string

B Hutton

http://www.w3.org/2001/XMLSchema#string

E Russell

http://www.w3.org/2001/XMLSchema#string

J Cox

http://www.w3.org/2001/XMLSchema#string

K Asakawa

http://www.w3.org/2001/XMLSchema#string

L McGahan

http://www.w3.org/2001/XMLSchema#string

M Clark

http://www.w3.org/2001/XMLSchema#string

M Severn

http://www.w3.org/2001/XMLSchema#string

M Sharma

http://www.w3.org/2001/XMLSchema#string

S Banerjee

http://www.w3.org/2001/XMLSchema#string

P2860

Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation

Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow-up results of a randomized study

Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO

Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up

The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention: a Swedish analysis of the CREDO trial

Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents

P304

e2103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23002375

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

P932

3442611

http://www.w3.org/2001/XMLSchema#string